Hypoxia News and Research

RSS
Hypoxia is a condition in which there is a decrease in the oxygen supply to a tissue. In cancer treatment, the level of hypoxia in a tumor may help predict the response of the tumor to the treatment.
Early MSC transplantation can help repair neonatal brain damage

Early MSC transplantation can help repair neonatal brain damage

Merck Serono enters development agreement with Threshold for hypoxia-targeted drug

Merck Serono enters development agreement with Threshold for hypoxia-targeted drug

Exercise under hypoxic conditions provides improvements in glycemic control

Exercise under hypoxic conditions provides improvements in glycemic control

Research advances understanding of hypoxic response

Research advances understanding of hypoxic response

First genome-wide study of high-altitude adaptations in Ethiopians

First genome-wide study of high-altitude adaptations in Ethiopians

Nitroglycerin can boost body's natural immune response to cancer

Nitroglycerin can boost body's natural immune response to cancer

Molecular signature indicative of hypoxia predicts progression to AD

Molecular signature indicative of hypoxia predicts progression to AD

Positive dose-escalation/expansion data from Array BioPharma's ARRY-614 Phase 1 MDS study

Positive dose-escalation/expansion data from Array BioPharma's ARRY-614 Phase 1 MDS study

TLRs contribute to brain damage following hypoxia in newborns

TLRs contribute to brain damage following hypoxia in newborns

ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement

ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement

ZIOPHARM announces new preclinical data from two darinaparsin studies on solid tumors

ZIOPHARM announces new preclinical data from two darinaparsin studies on solid tumors

Cerulean to present positive CRLX101 progression-free survival time results at 2011 AACR-NCI-EORTC

Cerulean to present positive CRLX101 progression-free survival time results at 2011 AACR-NCI-EORTC

Combination of REGN910 and aflibercept inhibits tumor angiogenesis in animal models

Combination of REGN910 and aflibercept inhibits tumor angiogenesis in animal models

Brain hypoxia associated with poor short-term outcome after severe TBI

Brain hypoxia associated with poor short-term outcome after severe TBI

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Preventive use of ACZ may reduce risk of severe high altitude illness

Preventive use of ACZ may reduce risk of severe high altitude illness

Mathematical optimization models to improve radiation therapy for cancer

Mathematical optimization models to improve radiation therapy for cancer

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

NO could improve recovery of critically ill patients in intensive care

NO could improve recovery of critically ill patients in intensive care

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.